Immunotherapy drug shows promise for reversing Pre-Cancerous lung changes in heavy smokers
NCT ID NCT03347838
First seen Dec 15, 2025 · Last updated May 13, 2026 · Updated 14 times
Summary
This study tests whether the drug nivolumab can reverse pre-cancerous spots in the lungs of heavy smokers or former smokers who are at high risk for lung cancer. Nineteen participants received the drug to see if their lung tissue improved over six months. The goal is to stop these spots from turning into cancer, though ongoing monitoring is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO SMOKING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Denver VA Hospital
Denver, Colorado, 80220, United States
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.